Group One Trading’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.3M | Buy |
48,300
+28,300
| +142% | +$21.7M | 0.07% | 262 |
|
|
2025
Q4 | $15.4M | Sell |
20,000
-22,900
| -53% | -$15.6M | 0.03% | 684 |
|
|
2025
Q3 | $24.1M | Buy |
42,900
+38,200
| +813% | +$21.6M | 0.04% | 428 |
|
|
2025
Q2 | $2.47M | Buy |
4,700
+1,200
| +34% | +$670K | 0.01% | 1930 |
|
|
2025
Q1 | $2.22M | Buy |
3,500
+3,400
| +3,400% | +$2.34M | 0.01% | 1730 |
|
|
2024
Q4 | $71.2K | Hold |
100
| – | – | ﹤0.01% | 4798 |
|
|
2024
Q3 | $105K | Hold |
100
| – | – | ﹤0.01% | 4135 |
|
|
2024
Q2 | $105K | Sell |
100
-1,400
| -93% | -$1.36M | ﹤0.01% | 3927 |
|
|
2024
Q1 | $1.44M | Sell |
1,500
-1,100
| -42% | -$1.05M | 0.01% | 1766 |
|
|
2023
Q4 | $2.28M | Hold |
2,600
| – | – | 0.01% | 1756 |
|
|
2023
Q3 | $2.14M | Sell |
2,600
-700
| -21% | -$550K | 0.01% | 1591 |
|
|
2023
Q2 | $2.37M | Sell |
3,300
-12,700
| -79% | -$9.79M | 0.01% | 1546 |
|
|
2023
Q1 | $13.1M | Sell |
16,000
-3,600
| -18% | -$2.72M | 0.05% | 349 |
|
|
2022
Q4 | $14.1M | Buy |
19,600
+6,500
| +50% | +$4.8M | 0.03% | 547 |
|
|
2022
Q3 | $9.02M | Buy |
13,100
+1,300
| +11% | +$818K | 0.02% | 793 |
|
|
2022
Q2 | $6.97M | Sell |
11,800
-12,400
| -51% | -$8.06M | 0.01% | 1079 |
|
|
2022
Q1 | $16.9M | Sell |
24,200
-20,700
| -46% | -$13.1M | 0.02% | 697 |
|
|
2021
Q4 | $28.4M | Buy |
44,900
+19,300
| +75% | +$11.9M | 0.02% | 512 |
|
|
2021
Q3 | $15.5M | Buy |
25,600
+20,700
| +422% | +$12.9M | 0.02% | 764 |
|
|
2021
Q2 | $2.74M | Sell |
4,900
-3,800
| -44% | -$1.93M | ﹤0.01% | 2314 |
|
|
2021
Q1 | $4.12M | Sell |
8,700
-38,000
| -81% | -$18.5M | 0.01% | 1717 |
|
|
2020
Q4 | $22.6M | Buy |
46,700
+41,100
| +734% | +$22.2M | 0.04% | 400 |
|
|
2020
Q3 | $3.13M | Sell |
5,600
-26,100
| -82% | -$15.8M | 0.01% | 1237 |
|
|
2020
Q2 | $19.8M | Buy |
31,700
+31,500
| +15,750% | +$17.9M | 0.09% | 231 |
|
|
2020
Q1 | $98K | Buy |
+200
| New | +$82.5K | ﹤0.01% | 3311 |
|
|
2016
Q2 | – | Sell |
-800
| Closed | -$288K | – | 4890 |
|
|
2016
Q1 | $288K | Hold |
800
| – | – | ﹤0.01% | 2077 |
|
|
2015
Q4 | $434K | Buy |
+800
| New | +$433K | 0.01% | 1927 |
|
|
2014
Q1 | – | Sell |
-100
| Closed | -$28K | – | 5513 |
|
|
2013
Q4 | $28K | Hold |
100
| – | – | ﹤0.01% | 4054 |
|
|
2013
Q3 | $31K | Hold |
100
| – | – | ﹤0.01% | 3899 |
|
|
2013
Q2 | $22K | Buy |
+100
| New | +$23.3K | ﹤0.01% | 4021 |
|
Other funds holding REGN
VCM
N
Group One Trading's REGN Position: Q1 2026 in Review
Group One Trading increased its Regeneron Pharmaceuticals (REGN) stake by 69% in Q1 2026, buying an estimated $1.69M and bringing the position to 5,399 shares worth $4.17M. The position accounts for 0.01% of the portfolio, ranked #1446.
Group One Trading first reported a position in REGN in Q2 2013 and has held it in 10 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Group One Trading held 5,399 shares of Regeneron Pharmaceuticals worth $4.17M as of Q1 2026.
- Group One Trading bought 2,207 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.69M.
- Regeneron Pharmaceuticals made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1446 holding.
- Group One Trading first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.